Search

everythinglearnresearchcommunity

for

Search:↓

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

Most patients with cutaneous lupus erythematosus in Bangladesh are young women, with chronic forms and photosensitivity being common.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Hydroxychloroquine effectively treated a woman's lupus skin issues and hair loss.

The CRH/CRH-R1 system might be involved in causing lichen planus.

Trichoscopy helps tell apart scalp lesions in pemphigus vulgaris and pemphigus foliaceus and is useful for choosing biopsy locations.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

Zinc is effective for treating various skin conditions, including warts and acne.

Young HS patients often have other physical and mental health issues, and research on HS covers a wide range of topics including genetics, triggers, treatments, and the need for more data.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

There is no gold standard treatment for hidradenitis suppurativa due to insufficient evidence.

Hair transplantation is an effective hair loss treatment with two main techniques, requires careful planning, and can improve beard and eyebrows appearance.

Choosing the right tools is crucial for accurately measuring lupus activity and damage.

Skin issues like hair loss, rash, and sensitivity to sunlight are key signs of lupus activity.

Early scar classification in lupus can improve treatment and patient outcomes.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Lower GPX4 mRNA levels are linked to higher disease activity and symptoms in lupus patients.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Skin issues can indicate immune system problems.